Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery
Launched by SINGAPORE NATIONAL EYE CENTRE · Jun 23, 2006
Trial Information
Current as of September 03, 2025
Completed
Keywords
ClinConnect Summary
AIMS OF STUDY:
This project seeks to evaluate the efficacy of fibrin glue (Tisseel) as an alternative to conventional sutures in ocular surface reconstruction, including pterygium excision with conjunctival autografting and other forms of conjunctival and amniotic membrane surgery.
It aims to evaluate the safety and efficacy of fibrin glue in pterygium and other forms of ocular surface conjunctival and amniotic membrane surgery, as an alternative to conventional suturing. We will perform conjunctival autografting in 30 patients with primary or recurrent pterygium, and in addition, up to 2...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. significant pterygium clinically requiring excision
- • 2. willingness to participate in research project and to attend research clinic
- Exclusion Criteria:
- • 1. age \< 18 years
- • 2. other concurrent corneal pathology
- • 3. poor acuity due to other ocular pathology
- • 4. poor general health
About Singapore National Eye Centre
The Singapore National Eye Centre (SNEC) is a premier institution dedicated to advancing ophthalmic care through innovative research and clinical excellence. As a leading clinical trial sponsor, SNEC focuses on improving the diagnosis and treatment of a wide range of eye conditions, leveraging cutting-edge technologies and methodologies. Committed to enhancing patient outcomes, SNEC collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the global understanding of ocular health. Their comprehensive approach integrates patient care with scientific inquiry, ensuring that advancements in eye care are both evidence-based and aligned with the needs of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Donald TH Tan, FRCOphth
Principal Investigator
Singapore Eye Research Institute
Yong M Por, FRCS
Principal Investigator
Singapore National Eye Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials